Antibodies of DCTN2


2 antibodies are included.     

 Released    NotSatisfied    Submitted    NotReviewed    OnHold    Submitting    Experimented   
RBP Antibody InfoPrimary-HepG2Secondary-HepG2Primary-K562Secondary-K562Primary-UBERONPrimary-Hela
DCTN2Product_ID: A303-488A
Lot_ID: 1
Source: Bethyl Labs
Target Name: DCTN2-human		 DCTN2-HEPG2-CRISPR-A303-488A.png<br>Caption: Western blot following CRISPR against DCTN2 in HepG2 whole cell lysate using DCTN2 specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against DCTN2. DCTN2 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.
 Bethyl_A303-488A_1_DCTN2.png<br>Caption: IP-WB analysis of K562 whole cell lysate using the DCTN2 specific antibody, A303-488A. Lanes 1 and 2 are 2.5% of five million whole cell lysate input and 50% of IP enrichment, respectively, using a normal IgG antibody. Lane 3 is 50% of IP enrichment from five million whole cell lysate using the DCTN2-specific antibody, A303-488A. The same antibody was used to detect protein levels via Western blot. This antibody passes preliminary validation and will be further pursued for secondary validation. *NOTE* Protein sizes are taken from Genecards.org and are only estimates based on sequence. Actual protein size may differ based on protein characteristics and electrophoresis method used.
 DCTN2-K562-CRISPR-A303-488A.png<br>Caption: Western blot following CRISPR against DCTN2 in K562 whole cell lysate using DCTN2 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against DCTN2. DCTN2 protein appears as the green arrow, Beta-actin serves as a control and appears in red arrow.
DCTN2Product_ID: A303-489A
Lot_ID: 1
Source: Bethyl Labs
Target Name: DCTN2-human		 Bethyl_A303-489A_1_DCTN2.png<br>Caption: IP-WB analysis of K562 whole cell lysate using the DCTN2 specific antibody, A303-489A. Lanes 1 and 2 are 2.5% of five million whole cell lysate input and 50% of IP enrichment, respectively, using a normal IgG antibody. Lane 3 is 50% of IP enrichment from five million whole cell lysate using the DCTN2-specific antibody, A303-489A. The same antibody was used to detect protein levels via Western blot. This antibody passes preliminary validation and will be further pursued for secondary validation. *NOTE* Protein sizes are taken from Genecards.org and are only estimates based on sequence. Actual protein size may differ based on protein characteristics and electrophoresis method used.
 DCTN2-K562-CRISPR-A303-489A.png<br>Caption: Western blot following CRISPR against DCTN2 in K562 whole cell lysate using DCTN2 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against DCTN2. DCTN2 protein appears as the green arrow, Beta-actin serves as a control and appears in red arrow.